GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genoway SA (STU:JEH) » Definitions » Net Income From Continuing Operations
中文

Genoway (STU:JEH) Net Income From Continuing Operations : €1.59 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genoway Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Genoway's net income from continuing operations for the six months ended in Jun. 2023 was €1.02 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2023 was €1.59 Mil.

Genoway Net Income From Continuing Operations Historical Data

The historical data trend for Genoway's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genoway Net Income From Continuing Operations Chart

Genoway Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.88 -0.49 -0.43 0.65 1.57

Genoway Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.20 0.47 1.02 0.57

Genoway Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genoway (STU:JEH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genoway SA (STU:JEH) » Definitions » Net Income From Continuing Operations
Comparable Companies
XPAR:GNRO XPAR:PHXM XPAR:ALVIO XPAR:ABNX XPAR:ALDVI XPAR:SIGHT XPAR:ALACT XPAR:ALCOX XPAR:ALCLS XPAR:POXEL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
ALGEN:France JEH:Germany
Address
181-203 avenue Jean Jaures, Lyon, FRA, 69007
Website
http://www.genoway.com
Genoway SA specializes in genetic designs to serve genetically modified (GM) mice, rat and cell lines for the biopharmaceutical industries and research industries.

Genoway (STU:JEH) Headlines

No Headlines